Histone deacetylase inhibitor for the treatment of hepatocellular carcinoma: Chemoimmunotherapeutic perspective and prospects

被引：4

作者：

Goto, Kaku ^{[1
]}

Kato, Naoya ^{[1
]}

机构：

[1] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Tokyo 1088639, Japan

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 04期

基金：

日本学术振兴会;

关键词：

GENOME-WIDE ASSOCIATION; CELLS; RESMINOSTAT; SORAFENIB; THERAPY;

D O I：

10.1016/j.jhep.2016.11.029

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：866 / 867

页数：2

共 10 条

[1] Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study [J].

Bitzer, Michael ;

Horger, Marius ;

Giannini, Edoardo G. ;

Ganten, Tom M. ;

Woerns, Marcus A. ;

Siveke, Jens T. ;

Dollinger, Matthias M. ;

Gerken, Guido ;

Scheulen, Max E. ;

Wege, Henning ;

Zagonel, Vittorina ;

Cillo, Umberto ;

Trevisani, Franco ;

Santoro, Armando ;

Montesarchio, Vincenzo ;

Malek, Nisar P. ;

Holzapfel, Julia ;

Herz, Thomas ;

Ammendola, Astrid S. ;

Pegoraro, Stefano ;

Hauns, Bernhard ;

Mais, Anna ;

Lauer, Ulrich M. ;

Henning, Stefan W. ;

Hentsch, Bernd .

JOURNAL OF HEPATOLOGY, 2016, 65 (02) :280-288

[2] Activation of mPTP-dependent mitochondrial apoptosis pathway by a novel pan HDAC inhibitor resminostat in hepatocellular carcinoma cells [J].

Fu, Meili ;

Shi, Wenhong ;

Li, Zhengling ;

Liu, Haiyan .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 477 (04) :527-533

[3] Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study [J].

Goto, Kaku ;

Annan, Dorcas A. ;

Morita, Tomoko ;

Li, Wenwen ;

Muroyama, Ryosuke ;

Matsubara, Yasuo ;

Ito, Sayaka ;

Nakagawa, Ryo ;

Tanoue, Yasushi ;

Jinushi, Masahisa ;

Kato, Naoya .

SCIENTIFIC REPORTS, 2016, 6

[4] MICA SNPs and the NKG2D system in virus-induced HCC [J].

Goto, Kaku ;

Kato, Naoya .

JOURNAL OF GASTROENTEROLOGY, 2015, 50 (03) :261-272

[5] Sorafenib Inhibits the Shedding of Major Histocompatibility Complex Class I-Related Chain A on Hepatocellular Carcinoma Cells by Down-Regulating a Disintegrin and Metalloproteinase 9 [J].

Kohga, Keisuke ;

Takehara, Tetsuo ;

Tatsumi, Tomohide ;

Ishida, Hisashi ;

Miyagi, Takuya ;

Hosui, Atsushi ;

Hayashi, Norio .

HEPATOLOGY, 2010, 51 (04) :1264-1273

[6] Novel immune modulators used in hematology: impact on NK cells [J].

Krieg, Stephanie ;

Ullrich, Evelyn .

FRONTIERS IN IMMUNOLOGY, 2013, 3

[7] Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma [J].

Kumar, Vinod ;

Kato, Naoya ;

Urabe, Yuji ;

Takahashi, Atsushi ;

Muroyama, Ryosuke ;

Hosono, Naoya ;

Otsuka, Motoyuki ;

Tateishi, Ryosuke ;

Omata, Masao ;

Nakagawa, Hidewaki ;

Koike, Kazuhiko ;

Kamatani, Naoyuki ;

Kubo, Michiaki ;

Nakamura, Yusuke ;

Matsuda, Koichi .

NATURE GENETICS, 2011, 43 (05) :455-+

[8]

Ledford H, 2016, NATURE, V532, P162, DOI 10.1038/532162a

[9] Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model [J].

Li, Guangfu ;

Liu, Dai ;

Cooper, Timothy K. ;

Kimchi, Eric T. ;

Qi, Xiaoqiang ;

Avella, Diego M. ;

Li, Ningfei ;

Yang, Qing X. ;

Kester, Mark ;

Rountree, C. Bart ;

Kaifi, Jussuf T. ;

Cole, David J. ;

Rockey, Don C. ;

Schell, Todd D. ;

Staveley-O'Carroll, Kevin F. .

JOURNAL OF HEPATOLOGY, 2017, 66 (01) :75-85

[10] Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2? [J].

Robert, Lidia ;

Ribas, Antoni ;

Hu-Lieskovan, Siwen .

SEMINARS IN IMMUNOLOGY, 2016, 28 (01) :73-80

← 1 →